These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24039183)

  • 21. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
    Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F
    Transplantation; 2013 May; 95(10):1284-91. PubMed ID: 23507699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation.
    Iori AP; Cerretti R; De Felice L; Screnci M; Mengarelli A; Romano A; Caniglia M; Cerilli L; Gentile G; Moleti ML; Giona F; Agostini F; Pasqua I; Perrone MP; Pinto MR; Grapulin L; Testi AM; Martino P; De Rossi G; Mandelli F; Arcese W
    Bone Marrow Transplant; 2004 Jun; 33(11):1097-105. PubMed ID: 15094744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Unrelated cord blood transplantation for the treatment of hematological malignancies].
    Ren HY; Zhang YC; Huang XJ; Xu LP; Liu KY; Li D; Guo NL; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):82-5. PubMed ID: 12697102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
    Bradstock KF; Hertzberg MS; Kerridge IH; Svennilson J; McGurgan M; Huang G; Antonenas V; Gottlieb DJ
    Intern Med J; 2006 Jun; 36(6):355-61. PubMed ID: 16732860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
    Gluckman E; Rocha V; Ionescu I; Bierings M; Harris RE; Wagner J; Kurtzberg J; Champagne MA; Bonfim C; Bittencourt M; Darbyshire P; Fernandez MN; Locatelli F; Pasquini R;
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1073-82. PubMed ID: 17697970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unrelated cord blood transplantation in children--a 10-year experience from UMMC.
    Chan LL; Lin HP; Chong LA; Hany A; Ariffin AW
    Med J Malaysia; 2009 Jun; 64(2):124-9. PubMed ID: 20058571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of granulocyte-macrophage colony-stimulating factor in two children treated with cord blood transplantation.
    Vowels MR; Tiedemann K; Lam-Po-Tang R; Tucker DP
    Blood Cells; 1994; 20(2-3):249-54; discussion 254-5. PubMed ID: 7749102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cord blood transplantation in Western Australia.
    Purtill D; Cooney J; Cannell P; Herrmann R; Trimboli F; Carter T; Baker D; Cole C
    Intern Med J; 2012 Sep; 42(9):1008-13. PubMed ID: 21981267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
    Gluckman E; Rocha V; Arcese W; Michel G; Sanz G; Chan KW; Takahashi TA; Ortega J; Filipovich A; Locatelli F; Asano S; Fagioli F; Vowels M; Sirvent A; Laporte JP; Tiedemann K; Amadori S; Abecassis M; Bordigoni P; Diez B; Shaw PJ; Vora A; Caniglia M; Garnier F; Ionescu I; Garcia J; Koegler G; Rebulla P; Chevret S;
    Exp Hematol; 2004 Apr; 32(4):397-407. PubMed ID: 15050751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma-depleted or -reduced cord blood.
    Petz L; Jaing TH; Rosenthal J; Karanes C; Nademanee A; Chan LL; Graham ML; Lin HP; Tan P; Wang BC; Fu C; Chow M; Forman S; Chow R
    Transfusion; 2012 Jun; 52(6):1311-20. PubMed ID: 22098396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders.
    Kwon M; Balsalobre P; Serrano D; Pérez Corral A; Buño I; Anguita J; Gayoso J; Diez-Martin JL
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):143-9. PubMed ID: 22960386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
    Wirk B; Klumpp TR; Ulicny J; Herman JH; Gajewski JL; Martin ME; Emmons RV; Mangan KF
    Transfusion; 2008 Jan; 48(1):163-8. PubMed ID: 17900280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.
    Gluckman E; Rocha V; Boyer-Chammard A; Locatelli F; Arcese W; Pasquini R; Ortega J; Souillet G; Ferreira E; Laporte JP; Fernandez M; Chastang C
    N Engl J Med; 1997 Aug; 337(6):373-81. PubMed ID: 9241126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
    Sanz J; Boluda JC; Martín C; González M; Ferrá C; Serrano D; de Heredia CD; Barrenetxea C; Martinez AM; Solano C; Sanz MA; Sanz GF;
    Bone Marrow Transplant; 2012 Oct; 47(10):1287-93. PubMed ID: 22327127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
    Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
    Bone Marrow Transplant; 2008 Nov; 42(10):643-8. PubMed ID: 18762760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.
    Sanz J; Sanz MA; Saavedra S; Lorenzo I; Montesinos P; Senent L; Planelles D; Larrea L; Martín G; Palau J; Jarque I; Martínez J; de la Rubia J; Moscardó F; Romero M; Luna I; Montava A; Cañabate S; Sanz GF
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):86-94. PubMed ID: 19744570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
    Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.
    Law J; Cowan MJ; Dvorak CC; Musick L; Long-Boyle JR; Baxter-Lowe LA; Horn B
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1656-63. PubMed ID: 22609040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
    Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ;
    N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.